|
Subpopulations of Human Dendritic Cells
|
5R01CA078846-10
|
$292,811
|
$73,203
|
Banchereau, Jacques
|
BAYLOR RESEARCH INSTITUTE
|
|
Targeting Deceoy Receptor 3 in Breast Cancer
|
1R43CA128176-01A2
|
$335,322
|
$335,322
|
Kim, Sunghee
|
BIOPOWERTECH
|
|
Heat shock proteins in cancer and signaling
|
5R01CA081244-10
|
$343,115
|
$68,623
|
SHERMAN, MICHAEL
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Epstein-Barr Virus LMP-1 Mediated Oncogenicity
|
5R01CA085180-08
|
$726,878
|
$726,878
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Modulation of Host Cell Apoptotic Responses by HPVE7
|
5R01CA081135-10
|
$282,084
|
$141,042
|
Munger, Karl
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
SIGNAL TRANSDUCTION AND CELL DEATH REGULATION
|
5P01CA069381-13
|
$1,715,290
|
$343,058
|
REED, JOHN
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
Inflammation-regulated microRNA in B cell lymphoma
|
1R01CA135531-01
|
$381,207
|
$125,798
|
RICKERT, ROBERT
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA030199-28
|
$3,649,220
|
$109,477
|
VUORI, KRISTIINA
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
Mechanisms of Prostate Cancer Chemoprevention by Apigenin
|
5R01CA108512-05
|
$228,488
|
$57,122
|
GUPTA, SANJAY
|
CASE WESTERN RESERVE UNIVERSITY
|
|
TRAIL Therapy for Rhabdomyosacrcoma
|
5R01CA087952-07
|
$234,840
|
$117,420
|
HOUGHTON, JANET
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Activators and repressors of NFkappaB and IRF3/7 in innate immunity
|
2R01CA095851-06
|
$272,927
|
$81,878
|
STARK, GEORGE
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
IFNs and Cytokines: Signaling and Action
|
5P01CA062220-14
|
$1,949,778
|
$1,559,822
|
STARK, GEORGE
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Tumor Gangliosides and TNF Synergize for T Cell Death
|
5R01CA111917-04
|
$257,865
|
$257,865
|
TANNENBAUM, CHARLES
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S1
|
$124,531
|
$1,245
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S2
|
|
$0
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S3
|
$49,998
|
$500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S4
|
$143,383
|
$1,434
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S5
|
|
$0
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-44
|
$11,641,774
|
$116,418
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
DF/HCC SPORE in Gastrointestinal Cancer
|
5P50CA127003-02
|
$2,300,001
|
$460,000
|
FUCHS, CHARLES
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-34S4
|
$9,979,932
|
$99,799
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-34S5
|
$60,810
|
$608
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-34S6
|
$264,000
|
$2,640
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Immunogenetics of Cervical and Vulvar Cancer
|
5R01CA112512-04
|
$607,277
|
$607,277
|
Schwartz, Stephen
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Effect of exercise and weight loss on adipose tissue biology
|
1R21CA131676-01
|
$198,000
|
$49,500
|
ULRICH, CORNELIA
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Differentially Regulating Apoptosis by AR: Activating Bax or Inhibiting JNK MAPK
|
1R01CA128114-01A1
|
$305,439
|
$152,720
|
XIANG, JIALING
|
ILLINOIS INSTITUTE OF TECHNOLOGY
|
|
Role of Kupffer Cell in Hepatic Carcinogenesis
|
5R01CA100908-04
|
$226,529
|
$113,265
|
KLAUNIG, JAMES
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
2P30CA082709-10
|
$1,301,405
|
$13,014
|
WILLIAMS, STEPHEN
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
3P30CA082709-10S1
|
$49,258
|
$493
|
WILLIAMS, STEPHEN
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
GC-C agonists for colitis-induced CRC
|
1R21CA133689-01A1
|
$202,012
|
$50,503
|
SHAILUBHAI, KUNWAR
|
INSTITUTE FOR HEPATITIS & VIRUS RESEARCH
|
|
Experimental Therapy of Cancer by Costimulated Immunity
|
5R01CA085721-09
|
$325,256
|
$97,577
|
Chen, Lieping
|
JOHNS HOPKINS UNIVERSITY
|
|
MOLECULAR MECHANISMS OF TUMOR-INDUCED TOLERANCE
|
5R01CA097085-07
|
$363,450
|
$72,690
|
Chen, Lieping
|
JOHNS HOPKINS UNIVERSITY
|
|
Hematopoietic Stem Cells for Transplantation
|
2P01CA070970-10A1
|
$2,035,680
|
$81,427
|
CIVIN, CURT
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-46
|
$7,420,697
|
$74,207
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Nanoparticles and Nanocapsules for Glioma Targeting
|
1R43CA135906-01
|
$400,001
|
$200,001
|
LARSEN, GUSTAVO
|
LNKCHEMSOLUTIONS
|
|
GVL without GVHD across HLA barriers: Translational Studies
|
5P01CA111519-03
|
$1,650,432
|
$825,216
|
Sykes, Megan
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
BLys inhibition using TACI-Fc in patients with B-bell non-Hodgkins' Lymphoma
|
5R21CA121569-02
|
$281,200
|
$281,200
|
ANSELL, STEPHEN
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Molecular Epidemiology of NHL and CLL
|
2R01CA092153-06
|
$629,749
|
$62,975
|
CERHAN, JAMES
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-34S1
|
$49,999
|
$500
|
DIASIO, ROBERT
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-34S2
|
$98,232
|
$982
|
DIASIO, ROBERT
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
5P30CA015083-34
|
$5,235,021
|
$52,350
|
DIASIO, ROBERT
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
role of BLyS/April in Normal and Malignant Plasma Cells
|
5R01CA105258-05
|
$258,035
|
$129,018
|
Jelinek, Diane
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Promoting Tumor Immunity by Cross-Linking B7-DC
|
2R56CA104996-05
|
|
$0
|
PEASE, LARRY
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Histone Deacetylase Inhibitor Based Therapy of AML
|
5R01CA123207-02
|
$251,370
|
$62,843
|
BHALLA, KAPIL
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
|
Use p105(sr) to study p50 homodimer in skin tumor/cancer
|
5R01CA104912-05
|
$203,349
|
$50,837
|
LIN, LI
|
MEDSTAR RESEARCH INSTITUTE
|
|
p53 - Regulators and Effectors
|
5P01CA080058-09
|
$1,348,536
|
$445,017
|
AARONSON, STUART
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
T Cell Alternative p38 Activation Pathway
|
Z01 BC 010774
|
$431,955
|
$215,978
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
Regulation and Consequences of Ubiquitination
|
Z01 BC 010779
|
$431,955
|
$431,956
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
T Cell Memory
|
Z01 BC 010932
|
$215,977
|
$64,793
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
Prostate cancer study in Shanghai
|
Z01 CP010180-01140
|
$36,044
|
$3,604
|
Hsing, Ann
|
DCEG (NCI)
|
Total relevant funding to Tumor Necrosis Factor for this search: $26,007,370
|